CED Studienzentrum Karlshorst
  • CED studies for participants
  • Study partner for IBD studies
  • English
    • German
Select Page

Ulcerative colitis: MIRACLE study – Study partners

by Pauline Lauterbach | Jan 16, 2026 | Active, Searching, For study partners

Ulcerative colitis: MIRACLE study – Study partners Efficacy of top-down therapy with mirikizumab compared to standard therapy with azathioprine in patients with newly diagnosed moderate to severe ulcerative colitis (MIRACLE) ClinicalTrials.gov ID: NCT07235904Sponsor:...

Crohn’s Disease: SAR441566 Study – Study Partner

by Pauline Lauterbach | Jan 16, 2026 | Active, Searching, For study partners

Crohn’s Disease: SAR441566 Study – Study Partner A study to investigate the efficacy and safety of SAR441566 in patients with Crohn’s disease (SPECIFI-CD) ClinicalTrials.gov ID: NCT06637631Sponsor: Sanofi (Information provided by Sanofi (responsible...

Recent Posts

  • Crohn’s disease: Study on the efficacy and safety of risankizumab (FORTIFY)
  • Crohn’s disease: Study on subcutaneous guselkumab (GRAVITI)
  • Crohn’s disease: Combination study with guselkumab and golimumab in Crohn’s disease (DUET-CD)
  • Ulcerative colitis: Combination study with guselkumab and golimumab (DUET-UC)
  • Ulcerative colitis: Study on the efficacy and safety of risankizumab

Recent Comments

No comments to show.

We look forward to receiving your contact request.



Ehrenfelsstr. 46, 10318 Berlin



Mon. - Fri. 9:00 AM - 5:00 PM



E-mail contact



+49 30 46309410

All studies are approved by an independent ethics committee and are conducted in accordance with international GCP standards.
Participation is voluntary and can be withdrawn at any time without disadvantage. Your data will be treated strictly confidentially in accordance with GDPR.

© CED Studienzentrum Berlin | Imprint | Privacy Policy | Accessibility Statement

  • Sprechstunde | Consultation
  • English
  • Deutsch (German)